Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiuppesi, Flavia, Salazar, Marcela d’Alincourt, Contreras, Heidi, Nguyen, Vu H, Martinez, Joy, Park, Soojin, Nguyen, Jenny, Kha, Mindy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Levytskyy, Roman, Ebelt, Nancy D, Kang, Tae Hyuk, Wu, Xiwei, Rogers, Thomas, Manuel, Edwin R, Shostak, Yuriy, Diamond, Don J, Wussow, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337387/
https://www.ncbi.nlm.nih.gov/pubmed/32637957
http://dx.doi.org/10.1101/2020.07.01.183236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337387/
https://www.ncbi.nlm.nih.gov/pubmed/32637957
http://dx.doi.org/10.1101/2020.07.01.183236

Ejemplares similares